Komori
M&A and Subsidiary Changes368AKitazato CorporationElectrical Equipment and Precision Instruments

Notice Regarding a Business Alliance in India and the Establishment of a Joint Venture (Consolidated Subsidiary)

The Company has entered into a business alliance with Repro Lifesciences LLP and plans to establish Kitazato India Private Limited, an Indian joint venture in which the Company will hold a 51% stake, in July 2026. Through the joint venture, the Company will provide regulatory support for its products, as well as sales promotion and technical support, with the aim of expanding its business in India.

Worth reading
37Immaterial
0–100. This measures how worthwhile something is to read, not how good or bad the company is.
Direction
Improvement
Direction inferred from the company’s description.
Scale
5000000
Indian rupees (capital of the joint venture)
Wording
Avoiding a definitive answer
How definitive the wording is.

This transaction

Business alliance and establishment of a joint venture
CounterpartyRepro Lifesciences LLP
Disclosing companyKitazato Corporation
Kitazato India Private Limited (planned)Voting rights ownership percentage

The voting-rights ratio is the share of the votes exercisable at a shareholders’ meeting that will be held after this transaction.The percentage before the change is not stated in this document.

TimelineThe spacing between the points is proportional to the actual number of days.
Target company

Regulatory approval support for the Company's products, market understanding, and customer services including technical support

Location IndiaShare capital 5,000,000 Indian rupees (¥8.5 million)Date of incorporation July 2026 (scheduled)
Net assets— (newly established)
Impact on Business Performance

The impact on consolidated results for the fiscal year ending March 2027 is expected to be immaterial.

Procedures and assumptions
Management structure after acquisitionThe name will be Kitazato India Private Limited (planned). The Managing Director will be Jatin Goel. The company is scheduled to be established in July 2026, and the Company plans to dispatch 2 directors and 1 corporate auditor. Employee treatment: Not disclosed.
This transaction
ItemDetails
Transaction nameBusiness alliance and establishment of a joint venture
Counterparty nameRepro Lifesciences LLP
Name of the Subject CompanyKitazato India Private Limited (planned)
Business Description of the Subject CompanyRegulatory approval support for the Company's products, market understanding, and customer services including technical support
Location of the Subject CompanyIndia
Capital Stock of the Subject Company5,000,000 Indian rupees (¥8.5 million)
Date of Establishment of the Subject CompanyJuly 2026 (scheduled)
Net Assets of the Subject Company— (newly established)
Voting rights ownership percentageAfter 51% (before not disclosed)
Impact on Business PerformanceThe impact on consolidated results for the fiscal year ending March 2027 is expected to be immaterial.
Date of board resolution15 June 2026
Contract Date16 June 2026 (planned)
Execution Date / Effective DateJuly 2026 (planned) (date of establishment), October 2026 (planned) (business commencement date)
Management structure after acquisitionThe name will be Kitazato India Private Limited (planned). The Managing Director will be Jatin Goel. The company is scheduled to be established in July 2026, and the Company plans to dispatch 2 directors and 1 corporate auditor. Employee treatment: Not disclosed.
Items this document does not state (18)
Net Sales of the Subject CompanyOperating Profit of the Subject CompanyNet Income of the Subject CompanyAcquisition priceExpenses other than the acquisition priceType of ConsiderationMerger ratio/share exchange ratioTender offer priceMinimum number of shares to be purchasedTender offer periodNumber of shares acquiredFunding arrangementsGoodwill amountAmount of extraordinary income (loss)Valuation methodologyIndependent valuation institutionSpecial CommitteeConditions Precedent to Execution

These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.

The reasons the company gives

The company's own explanation, not something inferred from the numbers.

To strengthen regulatory compliance, market and customer understanding, and its customer support structure in India. The Company aims to expand its business in the Indian market by establishing a local entity and enhancing sales promotion and technical support.

How to read this page

This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.
Notice Regarding a Business Alliance in India and the Establishment of a Joint Venture (Consolidated Subsidiary) | Kitazato Corporation (368A) timely disclosure | Komori